Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Nuclear Medicine and Biology|June 29, 2005
Synthesis and in vivo evaluation of [11C]PJ34, a potential radiotracer for imaging the role of PARP-1 in necrosisZhude Tu, Wenhua Chu, Jun Zhang, et al.
Biochemical and Biophysical Research Communications|March 29, 2017
Sigma-2 ligands and PARP inhibitors synergistically trigger cell death in breast cancer cellsElizabeth S McDonald, Julia Mankoff, Mehran Makvandi, et al.
Journal of Medicinal Chemistry|June 26, 2007
Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3/7 inhibitorsWenhua Chu, Justin Rothfuss, André d'Avignon, et al.
Bioorganic & Medicinal Chemistry|December 8, 2004
Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligandsWenhua Chu, Zhude Tu, Elizabeth McElveen, et al.
Nuclear Medicine and Biology|July 2, 2011
Effect of cyclosporin A on the uptake of D3-selective PET radiotracers in rat brainZhude Tu, Shihong Li, Jinbin Xu, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2006
Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosisDong Zhou, Wenhua Chu, Justin Rothfuss, et al.
Nuclear Medicine and Biology|September 9, 2018
Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancerDong Zhou, Jinbin Xu, Cedric Mpoy, et al.
Molecular Imaging and Biology|October 26, 2014
Imaging caspase-3 activation as a marker of apoptosis-targeted treatment response in cancerDelphine L Chen, Jacquelyn T Engle, Elizabeth A Griffin, et al.
Pageof 5